Association of O6-Methylguanine-DNA Methyltransferase Protein Expression With Postoperative Prognosis and Adjuvant Chemotherapeutic Benefits Among Patients With Stage II or III Gastric Cancer-Reference-Cited by-同舟云学术

Association of O6-Methylguanine-DNA Methyltransferase Protein Expression With Postoperative Prognosis and Adjuvant Chemotherapeutic Benefits Among Patients With Stage II or III Gastric Cancer

Published:2017-11-15 Issue:11 Volume:152 Page:e173120
ISSN:2168-6254
Container-title:JAMA Surgery
language:en
Short-container-title:JAMA Surg

Author:

Cao Yifan¹,Liu Hao²,Li He²,Lin Chao²,Li Ruochen¹,Wu Songyang¹,Zhang Heng²,He Hongyong²,Zhang Weijuan³,Xu Jiejie¹

Affiliation:

1. School of Basic Medical Sciences, Department of Biochemistry and Molecular Biology, Fudan University, Shanghai, China

2. Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China

3. School of Basic Medical Sciences, Department of Immunology, Fudan University, Shanghai, China

Publisher

American Medical Association (AMA)

Subject

Surgery

Reference37 articles.

1. Global cancer statistics, 2012.;Torre;CA Cancer J Clin,2015

2. Cancer statistics in China, 2015.;Chen;CA Cancer J Clin,2016

3. Gastric carcinoma.;Fuchs;N Engl J Med,1995

4. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.;De Vita;Br J Cancer,2005

5. Chemotherapy for colorectal cancer.;Moertel;N Engl J Med,1994

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and Molecular Mechanisms of Chemoresistance for Gastric Cancer;International Journal of General Medicine;2024-08

2. The integration of bulk and single-cell sequencing data revealed the function of FKBP10 in the gastric cancer microenvironment;Translational Cancer Research;2024-02

3. Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer;Clinical and Translational Medicine;2024-02

4. Remodeling the immune microenvironment for gastric cancer therapy through antagonism of prostaglandin E2 receptor 4;Genes & Diseases;2023-11

5. Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancer;Cancer Medicine;2023-08-21